Last reviewed 2026-04-23 · How we verify

Matching placebo of AYP-101

AMIpharm Co., Ltd. · Phase 3 active Small molecule

Matching placebo of AYP-101 is a Small molecule drug developed by AMIpharm Co., Ltd.. It is currently in Phase 3 development. Also known as: Placebo.

This is a matching placebo control and contains no active pharmaceutical ingredient.

At a glance

Generic name	Matching placebo of AYP-101
Also known as	Placebo
Sponsor	AMIpharm Co., Ltd.
Modality	Small molecule
Phase	Phase 3

Mechanism of action

Matching placebos are inert formulations designed to be indistinguishable from the active drug in appearance, taste, and administration route. They are used in blinded clinical trials to control for placebo effect and ensure valid comparison of the active drug's efficacy and safety. Since this is a placebo for AYP-101, it has no mechanistic activity.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Matching placebo of AYP-101 CI brief — competitive landscape report
Matching placebo of AYP-101 updates RSS · CI watch RSS
AMIpharm Co., Ltd. portfolio CI

Frequently asked questions about Matching placebo of AYP-101

What is Matching placebo of AYP-101?

Matching placebo of AYP-101 is a Small molecule drug developed by AMIpharm Co., Ltd..

How does Matching placebo of AYP-101 work?

This is a matching placebo control and contains no active pharmaceutical ingredient.

Who makes Matching placebo of AYP-101?

Matching placebo of AYP-101 is developed by AMIpharm Co., Ltd. (see full AMIpharm Co., Ltd. pipeline at /company/amipharm-co-ltd).

Is Matching placebo of AYP-101 also known as anything else?

Matching placebo of AYP-101 is also known as Placebo.

What development phase is Matching placebo of AYP-101 in?

Matching placebo of AYP-101 is in Phase 3.

Manufacturer: AMIpharm Co., Ltd. — full pipeline
Also known as: Placebo
Compare: Matching placebo of AYP-101 vs similar drugs
Pricing: Matching placebo of AYP-101 cost, discount & access